Vision And Resilience, The Hallmarks Of Axel Hoos’ Leadership Approach
A Q&A With Immuno-Oncology Pioneer
Executive Summary
Axel Hoos helped create the field of immuno-oncology and now has his sights on proving the worth of Scorpion Therapeutics’ precision oncology platform. The executive spoke with In Vivo about company culture, the Scorpion strategy and resilience in the face of resistance.